Form D · Other Health Care
X-Cor Therapeutics Inc.
Alston, MA · CIK 0001768464
Offering snapshot reported Feb 21, 2019 · SEC filing
- Reported sold
- $200K Offering amount: $2M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 31, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 21, 2019 | Initial | $200,002 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-333279
Series Seed 1 Preferred Stock
Source: Form D, filed Feb 21, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Chang | Director |
| Steven Keller | Director |
| Jayon Wang | Director, Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
127 Western Avenue
Alston, MA, 02134
Alston, MA, 02134